inavea™ CAROB ACACIA

Evidence Level
Moderate
2 Clinical Trials
6 Documented Benefits
3/5 Evidence Score

inavea™ carob acacia is an ALL-NATURAL organic synergistic prebiotic formulation developed by Nexira (France) — combining carob (Ceratonia siliqua) galactomannan and acacia gum arabinogalactan. Distinguished by ex vivo demonstrated boosted microbiota diversity (increased Community Modulation Score) at 5 g/day, full-spectrum colonic fermentation across entire intestine via different fiber structures, promotion of 29+ species of beneficial bacteria, and carbon neutral organic certification. Used to fortify nutritional powders, functional snacks, and shots.

Studied Dose 5 g/day (research-validated for microbiome diversity effects)
Active Compound Carob galactomannan + Acacia arabinogalactan polysaccharides

Benefits

Microbiota Diversity Enhancement

Distinct from many prebiotics that boost specific bacterial groups (e.g., Bifidobacterium-only). inavea™ carob acacia increases overall microbiota diversity — number of different bacterial species in gut. Diversity is among the strongest health-associated microbiome metrics.

Community Modulation Score (CMS) Improvement

Innovative metric (CMS) developed/applied by Nexira measures microbiota diversity changes; inavea™ carob acacia showed substantial improvements with 29+ bacterial species promoted. Established quantitative diversity benefit.

Full-Spectrum Intestinal Fermentation

Carob galactomannan and Acacia arabinogalactan have different physical structures and fermentation kinetics — combined effect spans entire intestine (proximal to distal colon). Acts across full colonic length.

SCFA Production (Beneficial Bacteria + Acids)

Synergistic SCFA production from combined fermentation; supports colonocyte health, gut barrier, immune function. Specific support for short-chain fatty acid producers.

FDA-Confirmed Dietary Fibers

Both acacia and carob are FDA-confirmed dietary fibers — enables fiber claims on food products in US market. Important regulatory positioning.

Carbon Neutral Organic

Carbon neutral footprint plus organic certification — sustainable and eco-conscious positioning.

Mechanism of action

1

Complementary Fiber Structure

Carob provides galactomannan (locust bean gum) — complex polysaccharide of mannose:galactose 4:1 ratio with gel-forming capacity. Acacia provides arabinogalactan — branched polysaccharide. Different structures = different bacterial fermentation profiles = synergistic effect.

2

Microbiota Diversity Mechanism

Different fibers feed different bacterial populations; combined fibers feed broader diversity vs single-fiber approach. Foundation for diversity-supportive effect.

3

Full-Length Colonic Fermentation

Acacia ferments slowly across full colon; carob galactomannan ferments somewhat differently. Combined effect provides substrate availability throughout colonic transit.

4

Gel-Forming + Free Polysaccharide

Carob's gel-forming property + acacia's free-flowing characteristics provide both structural and nutritional fermentation contributions. Different physical forms support different bacterial niches.

Clinical trials

1
inavea™ carob acacia Microbiota Diversity — Nexira Ex Vivo Study

Ex vivo intestinal system study of inavea™ carob acacia on microbiota composition.

Ex vivo intestinal model.

Significant prebiotic activities at 5 g/day equivalent; boosted microbiota diversity; 29+ beneficial bacterial species promoted; superior to individual carob or acacia alone.

2
Acacia and Carob Fiber Evidence Base
PubMed

Established prebiotic evidence for individual acacia and carob fibers.

Multiple study populations.

Both individually documented prebiotic effects; combined formulation with synergistic positioning logical extension.

Side effects and drug interactions

Common Potential side effects

Generally very well-tolerated.
Mild bloating with rapid introduction (any prebiotic).
Allergic reactions to legumes possible (carob is legume).
Gel-forming property may slow medication absorption.

Important Drug interactions

Fiber may delay medication absorption — separate by 1-2 hours.
Diabetes medications — modest hypoglycemic effects.
Cholesterol medications — modest additive effects.
Pregnancy/lactation — both ingredients widely consumed traditionally; supplementation generally safe.
Children — safe at appropriate proportional doses.

Frequently asked questions about inavea™ CAROB ACACIA

What is inavea CAROB ACACIA?

inavea™ carob acacia is an ALL-Natural organic synergistic prebiotic formulation developed by Nexira (France) — combining carob (Ceratonia siliqua) galactomannan and acacia gum arabinogalactan.

What is inavea CAROB ACACIA used for?

inavea CAROB ACACIA is researched primarily for Gut Health. Distinct from many prebiotics that boost specific bacterial groups (e.g., Bifidobacterium-only). inavea™ carob acacia increases overall microbiota diversity — number of different bacterial species in gut.

What is the recommended dosage of inavea CAROB ACACIA?

The clinically studied dose is 5 g/day (research-validated for microbiome diversity effects) Always follow the product label and check with a healthcare provider for personal advice.

Is inavea CAROB ACACIA safe, and does it have side effects?

For most healthy adults, inavea CAROB ACACIA is well tolerated at studied doses. Reported effects can include: Generally very well-tolerated. Mild bloating with rapid introduction (any prebiotic). It may also interact with some medications. inavea CAROB ACACIA is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does inavea CAROB ACACIA interact with any medications?

Possible interactions include: Fiber may delay medication absorption — separate by 1-2 hours. Diabetes medications — modest hypoglycemic effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for inavea CAROB ACACIA?

NutraSmarts rates the evidence for inavea CAROB ACACIA as Moderate (3 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Alarifi S, Bell A, Walton G In vitro fermentation of gum acacia - impact on the faecal microbiota. Int J Food Sci Nutr. 2018;69(6):696-704. doi: 10.1080/09637486.2017.1404970.PubMedUsed to support: In vitro fermentation study showing gum acacia (arabinogalactan — the acacia component of inavea carob acacia) selectively increases Bifidobacterium and Lactobacillus and produces acetate, propionate, and butyrate. Supports 'Full-Spectrum Intestinal Fermentation' and 'SCFA Production' claims for the acacia component.
  2. Micheletti C, Medori MC, Bonetti G, Iaconelli A, Aquilanti B, Matera G, Bertelli M Effects of Carob Extract on the Intestinal Microbiome and Glucose Metabolism: A Systematic Review and Meta-Analysis. Clin Ter. 2023;174(Suppl 2(6)):169-172. doi: 10.7417/CT.2023.2484.PubMedUsed to support: Systematic review and meta-analysis concluding that carob's pectin, galactomannan gums, and polyphenols (including pinitol) support balanced gut flora and improve glucose metabolism. Supports 'Microbiota Diversity Enhancement' and 'FDA-Confirmed Dietary Fibers' claims for the carob component.
  3. Milek Dos Santos L, Tomzack Tulio L, Fuganti Campos L, Ramos Dorneles M, Carneiro Hecke Krüger C Glycemic response to carob (Ceratonia siliqua L) in healthy subjects and with the in vitro hydrolysis index. Nutr Hosp. 2014;31(1):482-487. doi: 10.3305/nh.2015.31.1.8011.PubMedUsed to support: Human study in 7 healthy subjects showing carob (Ceratonia siliqua) produces a low glycemic index (~40) attributable to its 42–43% fiber content (predominantly insoluble). Supports carob's role as an FDA-confirmed dietary fiber with metabolic relevance; the slow fermentation of its galactomannan contributes to SCFA production downstream.
  4. Jarrar AH, Stojanovska L, Apostolopoulos V, Feehan J, Bataineh MF, Ismail LC, Al Dhaheri AS The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial. Nutrients. 2021;13(1):194. doi: 10.3390/nu13010194.PubMedUsed to support: Human RCT demonstrating gum arabic (acacia arabinogalactan) improves bowel quality and reduces appetite in metabolic syndrome-risk adults, supporting the 'Microbiota Diversity Enhancement' and 'SCFA Production' claims for the acacia component of the blend.